On 22 September 2020, the European Drug Report for 2019 was launched. The report provides a comprehensive analysis of recent drug use and market trends across the EU, Turkey, and Norway. The 2020 report focuses on the effects of the COVID-19 pandemic on drug use, supply, and services. Furthermore, it looks at the current and emerging trends in Europe’s drug situation up to 2020 and provides an overview of Europe’s drug situation regarding drugs such as cannabis, cocaine, amphetamines, and heroin. It also provides insight into drug-related infectious diseases and drug-related deaths and mortality. Emerging trends include:

• The increasing role of cocaine in Europe;
• The increased use of heroin;
• The need to better assess the relationship between problems with cannabis use and developments in the drug market;
• Increased and diverse drug production in Europe.

The report is accompanied by a summary of the main findings and an annual statistical bulletin.